NVS 240920 115.00C (NVS240920C115000) Stock Options, News & Quotes

6.40
+0.42+7.02%

15min DelayClose Aug 30 16:00 ET

6.40High6.40Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Arrayfunction

Aug 14 04:37

Talk about a blow to revenue! Shame how sick people don't have infinite money eh?

$Novartis AG (NVS.US)$
On Monday, a Delaware court denied the Swiss pharma giant's attempt for a preliminary injunction to block MSN Pharmaceuticals from launching their generic version on the U.S. market. 2024 guidance doesn't currently account for any generic releases of its best-selling drug Entresto in the U.S., the analysts say. "Should a generic Entresto get to the U.S. market, it would put about 1.5 billion U...

Options Newsman

Jul 15 03:48

Columns Options Volatility: Navigating Big Banks, Healthcare, and Tech Earnings

The earnings season is picking up speed, and this mid-July, we're about to get updates from some of the biggest names across various industries. Expect to hear from large banks, healthcare companies, airlines, and some of the tech and telecom giants that we all know.
The season started off last Friday with $JPMorgan (JPM.US)$ , $Wells Fargo & Co (WFC.US)$ , and $Wells Fargo & Co (WFC.US)$ sharing their numbers. They all did bett...

Meltyy

Jun 14 01:35

🚨 M&A Update! 🚨

Keep an eye on these recently announced M&As: 👀
$Merck & Co (MRK.US)$ to acquire EyeBio
$Biogen (BIIB.US)$ to acquire HI-Bio™
$Johnson & Johnson (JNJ.US)$ to acquire Proteologix
OnKure, Inc. merger with $Reneo Pharmaceuticals (RPHM.US)$
$Novartis AG (NVS.US)$ to acquire Mariana Oncology
What companies will be next? 🤔

life is a blessing

May 29 00:29

Esperion Therapeutics Is Now A Top Choice Takeover Target

$Esperion Therapeutics (ESPR.US)$ Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, have positioned it as defininte acquistion target for larger pharmaceutical companies. Esperion's drugs NEXLIZET and NEXLETOL now have primary prevention labels, NEXLIZET will soon become the drug of choice over a PCSK9 inhibitor says Texas based HeartPlace leading Cardio...

BullnBearTrading

Mar 17 22:23

What Happened Last Trade Day (Mar 15)

Stories you might have missed
Singapore’s private home sales down nearly half in February; 149 condos sold amid holiday lull
DEVELOPERS in Singapore sold 149 private homes in February, 47 per cent fewer than the 281 units moved in January, data released on Friday (Mar 15) by the Urban Redevelopment Authority showed.
Novartis invests US$256 million to expand Singapore plant
SWISS biopharma giant Novartis has invested US$256 million to expand its biopharm...